OVID icon

Ovid Therapeutics
OVID

Overview Fund Trends Analyst Outlook Journalist POV

55 hedge funds and large institutions have $74.5M invested in Ovid Therapeutics in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

50% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 24

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
55
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$116K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.2M
2
+$2.11M
3
+$1.32M
4
OMC
Oasis Management Company
Cayman Islands
+$148K
5
Renaissance Technologies
Renaissance Technologies
New York
+$83.8K

Top Sellers

1
-$4.1M
2
-$2.48M
3
-$1.57M
4
IC
Ikarian Capital
Texas
-$1.56M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$967K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$3K
52
$2.31K
53
$1K
54
–
55
–
56
–
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
1 2
3